Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Neutral Schroders (SDR) by JP Morgan
- Sell Jaywing (JWNG) by Steve Moore in ShareProphets
- Sell Jubilee Metals Group (JLP) by Tom Winnifrith in ShareProphets
- Sell Jubilee Metals Group (JLP) by Steve Moore in ShareProphets
- Sell Tribe Technology (TRYB) by Steve Moore in ShareProphets
- Outperform Hollywood Bowl Group (BOWL) by RBC Capital
- Buy JD Sports Fashion (JD.) by Harvey Jones in The Motley Fool
- Hold Legal & General Group (LGEN) by Harvey Jones in The Motley Fool
- Sell Gelion (GELN) by Steve Moore in ShareProphets
- Buy GSK (GSK) by Harvey Jones in The Motley Fool
- Neutral Synthomer (SYNT) by UBS
- Neutral Carvana Co Class A (0A79) by UBS
- Equal Weight United Utilities Group (UU.) by Barclays
- Overweight Workspace Group (WKP) by Barclays
- Equal Weight Safestore Holdings (SAFE) by Barclays
- Equal Weight Severn Trent (SVT) by Barclays
- Overweight Pennon Group (PNN) by Barclays
- Overweight Land Securities Group (LAND) by Barclays
- Overweight LondonMetric Property (LMP) by Barclays
- Overweight Convatec Group (CTEC) by Barclays
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,365 open tips for GSK (GSK)
| Latest Bid : 1,319.50p | Latest Ask : 1,320.50p |
| High Today : 1,322.50p | Low Today : 1,302.50p |
| This Years High : 1,812.50p | This Years Low : 1,300.00p |
| Volume : 5,886,023 | MKT Cap : £54734.73M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Harvey Jones | Premium Only | 2024-12-20 10:45:00 20/12/2024 | 0.65% |
| Underweight | JP Morgan | Premium Only | 2024-12-11 10:01:00 11/12/2024 | 3.12% |
| Underperform | Bank of America | Premium Only | 2024-12-09 12:06:00 09/12/2024 | -0.15% |
| Buy | Berenberg | Premium Only | 2024-12-02 05:50:00 02/12/2024 | -1.16% |
| Hold | Harvey Jones | Premium Only | 2024-11-27 16:25:00 27/11/2024 | -1.64% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1,319.50p | Latest Ask : 1,320.50p |
| High Today : 1,322.50p | Low Today : 1,302.50p |
| This Years High : 1,812.50p | This Years Low : 1,300.00p |
| Volume : 5,886,023 | MKT Cap : £54734.73M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Harvey Jones | Premium Only | 2024-12-20 10:45:00 20/12/2024 | 0.65% |
| Underweight | JP Morgan | Premium Only | 2024-12-11 10:01:00 11/12/2024 | 3.12% |
| Underperform | Bank of America | Premium Only | 2024-12-09 12:06:00 09/12/2024 | -0.15% |
| Buy | Berenberg | Premium Only | 2024-12-02 05:50:00 02/12/2024 | -1.16% |
| Hold | Harvey Jones | Premium Only | 2024-11-27 16:25:00 27/11/2024 | -1.64% |